Gyawali, B., Hey, S. P., & Kesselheim, A. S. (2020). Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs. EClinicalMedicine.
Citação norma ChicagoGyawali, Bishal, Spencer P. Hey, and Aaron S. Kesselheim. "Evaluating the Evidence Behind the Surrogate Measures Included in the FDA's Table of Surrogate Endpoints As Supporting Approval of Cancer Drugs." EClinicalMedicine 2020.
Citação norma MLAGyawali, Bishal, Spencer P. Hey, and Aaron S. Kesselheim. "Evaluating the Evidence Behind the Surrogate Measures Included in the FDA's Table of Surrogate Endpoints As Supporting Approval of Cancer Drugs." EClinicalMedicine 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.